Skip to main content
. 2020 Sep 25;4(12):bvaa140. doi: 10.1210/jendso/bvaa140

Figure 4.

Figure 4.

The proportion of patients currently (at the time of data collection) being treated with oral and/or IV glucocorticoids by specialty and subspecialty. “n” represents the number of patients reported by each specialty/subspecialty. “All ophthalmologists” includes general and ophthalmology subspecialty patients.